Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo
about
Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?The role of death-associated protein 3 in apoptosis, anoikis and human cancerEndoplasmic reticulum protein ERp46 in renal cell carcinomaCD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma.Deletion of Lkb1 in Renal Tubular Epithelial Cells Leads to CKD by Altering Metabolism.Potential applications for biguanides in oncologyMitochondrial and performance adaptations to exercise training in mice lacking skeletal muscle LKB1Rewiring cell polarity signaling in cancer.Underactivation of the adiponectin-adiponectin receptor 1 axis in clear cell renal cell carcinoma: implications for progression.Metabolic reprogramming in clear cell renal cell carcinoma.Methylation of STK11 promoter is a risk factor for tumor stage and survival in clear cell renal cell carcinoma.Endoplasmic reticulum protein ERp46 in prostate adenocarcinoma.Novel mutations and role of the LKB1 gene as a tumor suppressor in renal cell carcinoma.Metabolomics and Metabolic Reprogramming in Kidney Cancer.LKB1 loss at transcriptional level promotes tumor malignancy and poor patient outcomes in colorectal cancer.
P2860
Q26749088-60AF65F5-2106-4847-90A8-D854BBA430A6Q34043792-C0F084CA-3C43-4157-910E-AA98C1DC081BQ35110644-E41F390F-1D70-4616-908B-5735A8E59B7DQ35292720-DE09792F-677A-4603-B670-938666E9252EQ36514929-7C5E855C-FBB1-4CB2-A8FC-B596618FEF3EQ37123877-74CE1669-B0C9-4CF3-BB3D-E25520BA468EQ37234626-ECFF4C8C-21FD-41BB-A31B-886A4DBDBA95Q38196268-7FB37253-72A9-4813-B896-3BABD6D49C5EQ39085695-049A42ED-99D8-4BA5-A85C-9064483C63DBQ39290307-B371DBAB-5016-45F1-88ED-87702CB88E3FQ41614903-A242FD12-67CE-42C8-B06C-D2A689E7E111Q41811207-88AD109B-91E9-4F59-B7EB-691DB8960618Q48569709-4EBD661C-8E7D-4A61-A8D5-6B7E8168671BQ52618376-CAD70BED-2D66-4B0E-A6D2-8E5F6CCE27D1Q54348800-C194B144-9722-4227-BF7D-62AD181502C1
P2860
Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Underexpression of tumour supp ...... advantage in vitro and in vivo
@en
Underexpression of tumour supp ...... dvantage in vitro and in vivo.
@nl
type
label
Underexpression of tumour supp ...... advantage in vitro and in vivo
@en
Underexpression of tumour supp ...... dvantage in vitro and in vivo.
@nl
prefLabel
Underexpression of tumour supp ...... advantage in vitro and in vivo
@en
Underexpression of tumour supp ...... dvantage in vitro and in vivo.
@nl
P2093
P2860
P356
P1476
Underexpression of tumour supp ...... advantage in vitro and in vivo
@en
P2093
J H Pinthus
L K Beatty
R C Austin
W C Duivenvoorden
P2860
P2888
P304
P356
10.1038/BJC.2012.574
P407
P577
2013-01-15T00:00:00Z